Prevention in Cardiovascular Disease

Slides:

Advertisements

Similar presentations

Part 2: Recommendations for Hypertension Treatment

Advertisements

Today’s Agenda Discuss the prevention and management of cardiovascular complications of diabetes Mention the other complications along with prevention.

Educational Event 23rd & 24th January 2013

©LTPHN 2008 Blood Pressure – the highs and lows Speaker, name,affiliation,etc.

Uzma Haque GP Reg..  Education & Lifestyle Adjustments  Glucose control  Oral medications  Insulin therapy  CV risk estimation  Blood pressure 

National Service Frameworks Dr Stephen Newell February 2002.

Slides current until 2008 Nutritional needs of people with type 1 diabetes and type 2 diabetes.

Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

AF and NOACs An UPDATE JULY 2014

ATRIAL FIBRILLATION Hannah Morgan Lance Killian October 12, 2010 HS2.

Heart and Stroke diseases in South Asians ILMANA FASIH.

Atrial Fibrillation Current Management Strategies.

© 2010 Cengage-Wadsworth Ch. 11 Cardiovascular Disease 1. What is cardiovascular disease? #___ Cause of Death in the U.S. 2. How can I prevent it?

February is Heart & Stroke Awareness Month. Did you know???? Heart Disease and Stroke is Preventable if you know your RISK FACTORS.

Research CDC Standards

K Keep active and maintain a healthy body weight. Keep active and maintain a healthy body weight. A healthy body weight can reduce the risk for high blood.

Parks and Chronic Disease Management ●Diabetic individuals taking 30-minute walks in a forest experienced much lower blood glucose levels than the same.

NHS Health Checks Helping you prevent heart disease, stroke, diabetes and kidney disease.

Healthy Heart Vegetarian Cooking School and Lifestyle Class 4/27/10.

 Ischaemic heart disease reduces blood supply to the heart muscles and is one of the major cardiovascular diseases.

My Research Prospectus Hypertension: A Rising Problem in Today’s Society.

CVD MEETING 7/9/01: main topics CV CLINIC WITH SCREEN SHOTS AND AUDIT MANAGEMENT PROTOCOL WITH DRUGS AND RISK CALCULATION CHARTS ASPIRIN AUDIT.

PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.

Clinical pathway for people with atrial fibrillation or at risk of atrial fibrillation Dr Ruth Chambers OBE LTC Priority Lead, West Midlands Academic Health.

The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.

Improving Detection & Management of Atrial Fibrillation Brendan Young Lynda Dando.

Presented by Slyter Nutrition Consulting Services.

With an increase in the number of desk jobs, physical activities are coming to a standstill. As a major part of the day is spent in the office, the youth.

Copyright © 2015 by the American Osteopathic Association.

Helping you prevent heart disease, stroke, diabetes and kidney disease

Golden Rules to Keep Kidneys Healthy

Addressing the Challenges in Primary and Secondary Stroke Prevention

“Directionality” issues can be complex Cardiovascular Disease Clonal Hematopoiesis Age Smoking Obesity/Diabetes Hypertension Dyslipidemia Heritable Risk.

CHA2DS2-VASc Scoring System General AF Treatment Guidance.

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Anticoagulant Safety Remains a Problem Emergency Hospitalizations for Adverse Drug Events.

Chronic kidney disease and pre-dialysis

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

US Guidelines US Guidelines Low-risk Patients.

When Is Adding Aspirin to NOACs Worth the Risk?

Barriers to Oral Anticoagulant Use for Stroke Prevention in AF

Access to NOAC Therapy:

Stroke Risk Assessment

Nat. Rev. Cardiol. doi: /nrcardio

Oral Anticoagulants in AFa,b A Brief History.

NOAC Use in AF: REAL-WORLD Studies WITH REAL RESULTS

The Essentials for Secondary Stroke Prevention

New Oral Anticoagulants and VTE Management

Parks and Chronic Disease Management

Access to NOAC Therapy:

Adherence in SPAF: Measures to Improve Care

FAERS death cases (all years) for NOACs versus warfarin.

Oral Anticoagulation in AF

Dos and Don’ts for High-Risk Elderly Patients With AF

Atrial Fibrillation.

Journal of Indian College of Cardiology

John P. Middleton, Patrick H. Pun Kidney International

Hypertension management in high risk type II diabetes with CKD: Insights from recent trials with a focus on albuminuria. A case based discussion Matthew.

NOAC Studies in VTE AF Studies Superior Outcomes.

-.&- ·Af& Q 0 "i'/

What is cardiovascular disease?

ACC 2003 Late Breaking Trials

Erratum Canadian Journal of Cardiology

Conceptual model of the course of chronic kidney disease (CKD).

Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,

Figure 8. Stroke prevention strategy in patients with AF

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

Extraordinary Cases in Stroke Prevention

Presentation transcript:

Prevention in Cardiovascular Disease Healthy Lifestyle advice Known Cardiovascular Disease Known Occlusive Cardiovascular Disease No known Occlusive Cardiovascular Disease Type II Diabtetes CKD III Hypertension Cardiovascular Risk Assessment >10% at 10 years Atrovastatin 80mg Aspirin 75mg Blood pressure control Rate control if IHD Atrovastatin 80mg Blood pressure control Atrovastatin 40mg Blood pressure control Atrovastatin 40mg Continue healthy lifestyle and 3 yearly assessment If known AF offer oral anticoagulation with warfarin or a NOAC